2021
DOI: 10.5808/gi.21034
|View full text |Cite
|
Sign up to set email alerts
|

Molecular insights into the role of genetic determinants of congenital hypothyroidism

Abstract: In our previous studies, we have demonstrated the association of certain variants of the thyroid-stimulating hormone receptor (TSHR), thyroid peroxidase (TPO), and thyroglobulin (TG) genes with congenital hypothyroidism. Herein, we explored the mechanistic basis for this association using different in silico tools. The mRNA 3'-untranslated region (3'-UTR) plays key roles in gene expression at the post-transcriptional level. In TSHR variants (rs2268477, rs7144481, and rs17630128), the binding affinity of microR… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“…14 post-transcriptional (miRNAs) regulatory signatures regulated with them were determined.According to the miRNA-hub genes network and immune in ltration analysis,Hsa-miR-142-3p,hsa-miR-639,hsa-miR-3681,and hsa-miR-4280 were selected as potential therapeutic targets for AF.Among them, Aberrant activation of hsa-miR-142-3p can increase the expression of the target molecule BCL2L1, thus enabling excessive apoptosis of endothelial cells in hypertensive patients [26].Hsa-MiR-639 can be used as a biomarker to predict whether pediatric dilated cardiomyopathy can recover from after cardiac transplantation [27].By sponging hsa-miR-3681,SIRT1 gene could promote autophagy in inhibiting cardiac hypertrophy [28].Hsa-miR-4280 is disrupted in thyroid-stimulating hormone receptor variants, affecting post-transcriptional gene regulation [29].…”
Section: Table 2 List Of the Suggested Drugs For Af Discussionmentioning
confidence: 99%
“…14 post-transcriptional (miRNAs) regulatory signatures regulated with them were determined.According to the miRNA-hub genes network and immune in ltration analysis,Hsa-miR-142-3p,hsa-miR-639,hsa-miR-3681,and hsa-miR-4280 were selected as potential therapeutic targets for AF.Among them, Aberrant activation of hsa-miR-142-3p can increase the expression of the target molecule BCL2L1, thus enabling excessive apoptosis of endothelial cells in hypertensive patients [26].Hsa-MiR-639 can be used as a biomarker to predict whether pediatric dilated cardiomyopathy can recover from after cardiac transplantation [27].By sponging hsa-miR-3681,SIRT1 gene could promote autophagy in inhibiting cardiac hypertrophy [28].Hsa-miR-4280 is disrupted in thyroid-stimulating hormone receptor variants, affecting post-transcriptional gene regulation [29].…”
Section: Table 2 List Of the Suggested Drugs For Af Discussionmentioning
confidence: 99%
“…In addition to known mutations, the role of single nucleotide polymorphisms (SNPs) has been also investigated in CH. Different studies reported as polymorphic variants in TPO, TSHR and TG genes can represent a genetic risk factor for dishormonogentic CH [7][8][9][10].…”
Section: Introductionmentioning
confidence: 99%